Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Rev Mal Respir ; 39(5): 498-501, 2022 May.
Article in French | MEDLINE | ID: mdl-35570033

ABSTRACT

The relationship between infectious disease and therapy with immune checkpoint inhibitors remains unknown. We report the case of a 50-year-old woman with metastatic lung adenocarcinoma who responded remarkably well to immunotherapy and underwent upper right lobectomy. Three weeks after hospital discharge, she was readmitted for severe dyspnea due to mainstem bronchus compression by mediastinal mass. Histological analysis of transbronchial needle aspiration revealed A. fumigatus. After six months of voriconazole regimen, her symptoms improved with the regression of bronchial compression. Postoperative progression of pseudo-tumoral mass in patients treated with long-term immunotherapy may be related to opportunistic infectious disease and requires investigation.


Subject(s)
Lung Neoplasms , Mediastinitis , Aspergillus , Female , Humans , Immunotherapy , Lung/pathology , Lung Neoplasms/complications , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Mediastinitis/diagnosis , Mediastinitis/etiology , Mediastinitis/therapy , Middle Aged
2.
Rev Mal Respir ; 39(1): 34-39, 2022 Jan.
Article in French | MEDLINE | ID: mdl-35034830

ABSTRACT

Unplanned readmissions after lung cancer surgery impair normal postoperative recovery and are associated with increased postoperative mortality. The objective of this review was to compile a detailed and comprehensive dataset on unplanned readmissions after pulmonary resection so as to better understand the associated factors and how they may be attenuated. Based on the identified risk factors, prevention involves improved preoperative preparation of at-risk patients and preoperative discharge planning so as to help prevent unscheduled readmissions, which are predictive of a poorer prognosis.


Subject(s)
Patient Readmission , Postoperative Complications , Databases, Factual , Humans , Lung , Patient Discharge , Postoperative Complications/epidemiology , Retrospective Studies , Risk Factors
3.
J Med Vasc ; 42(4): 229-233, 2017 Jul.
Article in French | MEDLINE | ID: mdl-28705341

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the contribution of ultrasound guidance (UG) to vascular puncture in endovascular therapy. Ultrasound guidance was evaluated by comparison with the rates of failures and complications of the traditional techniques of percutaneous vascular access. MATERIALS AND METHODS: We reviewed all the consecutive percutaneous revascularizations (percutaneous transluminal angioplasty and/or stenting, treatment of aneurysms and vascular traumatisms) since the standardization of the systems of closing (extra- and endovascular). The UG began in November 2011. The main objectives of the evaluation were the rate of failure of the punctures and the rate of complications (hematoma requiring transfusion or surgery for hemostasis, false aneurysm, dissection, thrombosis, infection). The failures and the complications were compared between two groups UG- and UG+. RESULTS: Between January 2008 and December 2014, 841 punctures were carried out by femoral route (85%), brachial route (12%), popliteal route (1%), axillary route (0.5%), and posterior tibial route (0.5%) with introducers between 4F and 12F. There were 20 complications (2.3%): six hematomas, four pseudo-aneurysms, three thromboses, one nervous paralysis, one stent infection, and seven percutaneous failures. The complications and the failures were significantly lower with ultrasound guidance (0.9% vs. 3.6%; P=0.02, and 0.2% vs. 1.4%; P=0.01, respectively). CONCLUSION: Ultrasound guidance makes it possible to significantly decrease the rate of complications and failures of the percutaneous accesses. This tool allowed a clear increase in the realization of the percutaneous angioplasties in outpatient hospitalization.


Subject(s)
Angioplasty , Peripheral Arterial Disease/diagnostic imaging , Peripheral Arterial Disease/surgery , Surgery, Computer-Assisted , Ultrasonography, Interventional , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Punctures , Retrospective Studies
4.
J Med Vasc ; 42(3): 162-169, 2017 May.
Article in French | MEDLINE | ID: mdl-28705405

ABSTRACT

OBJECTIVES: Prevalence of abdominal aortic aneurysms (AAA) in Europe is between 4.1 % and 8.9 %. The risk of rupture of AAA is related to the evolution of its diameter. The role of sleep apnea (SA) remains still discussed. The objective of this study was to study the prevalence of SA in patients presenting with AAA in comparison with the general population as well as the relation between the AAA diameter and the severity of SA. MATERIALS AND METHODS: Between June 2012 and December 2014, we included all patients referred for surgical treatment of an AAA. All the patients had a preoperative polysomnography and angio-scanner. An apnea/hypopnea index (AHI)>10/h was chosen for the diagnosis of SA. SA prevalence was compared with the prevalence in general population. The patients were also divided into two groups according to the severity of SA: group 1 (no SA and light SAS); group 2 (moderate and severe SA). RESULTS: Fifty-two patients were included. Fifty-six percent of the patients presented SA - prevalence was significantly higher than in the general population (56 vs. 8 %, P<0.001). The distribution of the two groups was: group 1, n=27 patients, group 2, n=25 patients. AAA diameter and BMI were higher in group 2 than in group 1, respectively 61mm vs. 55mm, P=0.03 and 28 vs. 23, P=0.02. CONCLUSION: Prevalence of SA in patients with an AAA seems to be significantly higher than in general population. The growth of the aneurysm seems to be linked to the severity of SA.


Subject(s)
Aortic Aneurysm, Abdominal/complications , Sleep Apnea Syndromes/complications , Sleep Apnea Syndromes/epidemiology , Adult , Aged , Aged, 80 and over , Aortic Aneurysm, Abdominal/pathology , Female , Humans , Male , Middle Aged , Prevalence , Prospective Studies , Severity of Illness Index
5.
Ann Dermatol Venereol ; 144(1): 49-54, 2017 Jan.
Article in French | MEDLINE | ID: mdl-27527566

ABSTRACT

BACKGROUND: Certain anticancer drugs are known to induce leg ulcers, mainly chemotherapy agents such as hydroxyurea. We report 2 cases of leg ulcers in cancer patients treated with the tyrosine kinase inhibitors, sunitinib and nilotinib, and we discuss the role of these treatments in the pathogenesis of leg ulcers. PATIENTS AND METHODS: Case 1. A 62-year-old patient on sunitinib for intrahepatic cholangiocarcinoma developed a lesion on her right foot. The vascular evaluation was negative. After progressive worsening, sunitinib was stopped and healing was observed within a few months. Case 2. A 83-year-old patient had been treated for chronic myeloid leukemia since 2005. Nilotinib was introduced in 2009. Peripheral arterial revascularization was required in May 2013. A few months later, worsening was noted with the onset of ulceration and necrosis of the third toe. Further revascularisation surgery was performed, and nilotinib was suspended and antiplatelets introduced. Healing occurred a few months later. DISCUSSION: Many skin reactions have been described in patients on nilotinib and sunitinib, but few publications report the development of de novo ulcers in patients without risk factors. The pathophysiology of the development of ulcers in patients receiving tyrosine kinase inhibitors is not clear, and probably involves several mechanisms of action. The increasing use of this type of treatment could lead to an upsurge in the incidence of vascular complications. CONCLUSION: We report two cases of leg ulcers developing in patients on tyrosine kinase inhibitors and raise the question of causal implication of these treatments in the pathogenesis of ulcers.


Subject(s)
Antineoplastic Agents/adverse effects , Indoles/adverse effects , Leg Ulcer/chemically induced , Pyrimidines/adverse effects , Pyrroles/adverse effects , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Bile Duct Neoplasms/drug therapy , Cholangiocarcinoma/drug therapy , Female , Humans , Indoles/administration & dosage , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Male , Middle Aged , Pyrimidines/administration & dosage , Pyrroles/administration & dosage , Sunitinib , Withholding Treatment , Wound Healing
6.
Rev Mal Respir ; 33(10): 899-904, 2016 Dec.
Article in French | MEDLINE | ID: mdl-27282325

ABSTRACT

The objectives of outpatient surgery are to reduce the risks connected to hospitalization, to improve postoperative recovery and to decrease the health costs. Few studies have been performed in the field of thoracic surgery and there remains great scope for progress in outpatient lung surgery. The purpose of this article is to present a revue of the current situation and the prospects for the development of out patient thoracic surgery.


Subject(s)
Ambulatory Surgical Procedures , Thoracic Surgical Procedures , Ambulatory Surgical Procedures/methods , Ambulatory Surgical Procedures/standards , Ambulatory Surgical Procedures/statistics & numerical data , Ambulatory Surgical Procedures/trends , Humans , Patient Selection , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Practice Guidelines as Topic , Thoracic Surgery, Video-Assisted/statistics & numerical data , Thoracic Surgical Procedures/methods , Thoracic Surgical Procedures/standards , Thoracic Surgical Procedures/statistics & numerical data , Thoracic Surgical Procedures/trends
7.
Rev Mal Respir ; 33(5): 343-9, 2016 May.
Article in French | MEDLINE | ID: mdl-26520776

ABSTRACT

INTRODUCTION: The objectives of outpatient surgery are to reduce the risks related to the hospitalization, to improve the postoperative recovery and to optimize contact with family physicians. The objective of this work is to present the first unit of outpatient pulmonary surgery and to report the results of the resections of pulmonary nodules in outpatient surgery in the setting of early discharge. METHODS: The indications for the resection of nodules were discussed in a multidisciplinary thoracic oncology meeting. The patients underwent resection of one or more lung nodules by thoracoscopy after verification that they met the anaesthetic and surgical criteria for ambulatory surgery. We analyzed the characteristics of the population, the duration of surgery, the type of resection, the time of the chest drain removal and the postoperative follow-up. RESULTS: Between November 2013 and December 2014, 51 patients underwent sub-lobar pulmonary resections. Among them 7 patients (4 men and 3 women), with an average age of 57.6 years (39-64) and histories of malignant tumor, underwent 7 atypical resections and two segmentectomies in outpatient surgery (3 patients had two resections). The average operating time was 53.75min (30-90). The chest drain was removed before the third hour in 8 cases and on the third day in one case. The average tumor diameter was 10.375mm (6-23). The histology revealed a metastasis of colorectal carcinoma in 4 cases, a metastasis of a renal carcinoma in 1 case, an in situ adenocarcinoma in 1 case and a benign tumor in 3 cases. Neither recurrence nor complication was observed during an average follow-up of 6 months. CONCLUSION: Thanks to a protocol of early mobilisation and discharge included in a well established clinical care pathway, thoracoscopic resection of lung nodules is feasible, with safety in properly selected and prepared patients in outpatient surgery.


Subject(s)
Ambulatory Care/methods , Critical Pathways , Multiple Pulmonary Nodules/surgery , Pneumonectomy/rehabilitation , Thoracic Surgery, Video-Assisted/rehabilitation , Adult , Critical Pathways/organization & administration , Critical Pathways/standards , Female , Humans , Male , Middle Aged , Multiple Pulmonary Nodules/rehabilitation , Operative Time , Patient Discharge , Pneumonectomy/methods , Retrospective Studies , Thoracoscopy/methods , Thoracoscopy/rehabilitation , Time Factors
8.
J Mal Vasc ; 40(4): 259-64, 2015 Jul.
Article in French | MEDLINE | ID: mdl-26055520

ABSTRACT

INTRODUCTION: Bare-metal stents are used to treat arterial stenotic lesions. Morbidity and mortality are less important compared with other techniques. Drug-eluting balloons are often used to treat stent stenosis. We reported the case of a bare-metal stent infection after drug-eluting balloon and a review on the subject. MATERIAL AND METHOD: Two weeks after percutaneous transluminal angioplasty with paclitaxel-eluting balloon and a bare-metal stent, our patient presented an infection of the stent. Diagnosis was based on the clinical presentation, positron emission tomography findings and isolation of Propionibacterium granulosum in repeated blood cultures. Adapted antibiotic therapy was given for three months with removal of the surgical bare-stent. Antibiotic therapy was interrupted after a second positron emission tomography. A literature search (PubMed and Cochrane) was performed on the subject. RESULTS: We found 49 cases of peripheral bare-metal stent infection including our patient. This is a rare but serious complication with a high morbidity (25% amputation rate) and mortality (30%). It seems to be underestimated. Treatment is based on surgical ablation of the bare-metal stent and intravenous antibiotics. The role of the paclitaxel-eluting balloon is not clearly established but some authors believe that it can produce a local immunosuppression. CONCLUSION: We report the first case of bare-metal stent infection after paclitaxel-eluting balloon. This complication is rare and difficult to diagnose. Manifestations are often limited to skin signs. Functional and vital prognosis is poor.


Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Gram-Positive Bacterial Infections/etiology , Paclitaxel/adverse effects , Propionibacterium/isolation & purification , Prosthesis-Related Infections/etiology , Stents/adverse effects , Aged, 80 and over , Alloys , Amoxicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Arteriosclerosis Obliterans/complications , Arteriosclerosis Obliterans/surgery , Bacteremia/etiology , Bacteremia/microbiology , Coronary Disease/complications , Coronary Disease/therapy , Coronary Restenosis/therapy , Device Removal , Equipment Contamination , Female , Femoral Artery/surgery , Gentamicins/therapeutic use , Gram-Positive Bacterial Infections/diagnostic imaging , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/microbiology , Humans , Immunosuppressive Agents/adverse effects , Paclitaxel/administration & dosage , Paclitaxel/therapeutic use , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/therapeutic use , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Popliteal Artery/diagnostic imaging , Popliteal Artery/surgery , Propionibacterium/pathogenicity , Prosthesis-Related Infections/diagnostic imaging , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/microbiology , Tomography, Emission-Computed, Single-Photon
9.
Ann Dermatol Venereol ; 141(11): 682-4, 2014 Nov.
Article in French | MEDLINE | ID: mdl-25442472

ABSTRACT

BACKGROUND: Herein we report a case of phlegmasia cerulea dolens, a form of venous thrombosis complicated by arterial ischaemia. PATIENTS AND METHODS: A 69-year-old man presented a bilateral trophic condition of the lower limbs that had appeared 3 weeks earlier. The patient had a history of metastatic urothelial bladder carcinoma and arteritis. Clinical examination revealed right leg ulcers with massive bilateral oedema of the lower limbs, cyanosis and local ischaemia. Doppler ultrasound revealed bilateral and proximal deep vein thrombosis (sural and superficial femoral veins of the right leg; sural and iliac veins of the left leg) without any distal arterial flow. We concluded on a diagnosis of bilateral phlegmasia cerulea dolens. DISCUSSION: Phlegmasia cerulea dolens is a particular type of deep venous thrombosis in which a proximal venous thrombus is combined with arterial ischaemic signs due to brutal and massive oedema and slowing down of arterial flow. In most cases, the lower limbs are involved, with malignancy being the most common cause. It should be suspected in the presence of the classical triad of "pain, oedema and cyanosis", with confirmation by Doppler ultrasound. There is no general consensus regarding standard management. Traditionally, systemic anticoagulation has been the mainstay of treatment for this condition. Endovascular surgery may be a possibility in some cases. Prompt diagnosis and rapid treatment initiation are paramount in order to improve the prognosis of this severe condition with ominous prospects.


Subject(s)
Arteritis/diagnostic imaging , Ischemia/diagnostic imaging , Leg/blood supply , Thrombophlebitis/diagnostic imaging , Venous Thrombosis/diagnostic imaging , Aged , Carcinoma/secondary , Carcinoma/surgery , Diagnosis, Differential , Edema/diagnosis , Femoral Vein/diagnostic imaging , Humans , Iliac Vein/diagnostic imaging , Leg Ulcer/diagnosis , Lymphatic Metastasis/pathology , Male , Ultrasonography, Doppler/methods , Urinary Bladder Neoplasms/surgery , Urothelium/pathology
10.
Rev Mal Respir ; 30(5): 414-9, 2013 May.
Article in French | MEDLINE | ID: mdl-23746815

ABSTRACT

INTRODUCTION: The benefits of a rehabilitation program before surgical lung cancer resection remain to be defined. The purpose of this prospective observational study was to assess the effects of rehabilitation together with the use of noninvasive ventilation (NIV) in patients who were at a high operative risk. METHODS: Between January 2010 and June 2011, 20 consecutive patients (16 males, four females, mean age: 66 years [44-79]) with a clinical N0 non-small cell lung cancer were included. Eligibility criteria were predicted post-operative respiratory function (FEV1, VO2 max) below the guideline thresholds for eligibility for surgical resection and/or associated with severe co-morbidities. The protocol included a cardiorespiratory rehabilitation program and 3 hours of NIV each day. Functional tests were repeated after 3 weeks of therapy. RESULTS: Participants displayed a significant increase in their FEV1 and VO2 max, which allowed surgical resection to go ahead in all patients (lobectomy, n=15; pneumonectomy, n=3; bilobectomy, n=2). The morbidity rate was 20% (acute renal failure, n=2; pneumonia, n=1; haemothorax, n=1). The mortality rate was 5% (myocardial infarction, n=1). Further postoperative rehabilitation allowed a return at home in 19 patients after a mean hospital stay of 11 days. CONCLUSION: Pulmonary rehabilitation associated with a period of preoperative NIV allows surgery to be performed in patients who are not initially eligible for resection. An evaluation of long-term outcomes survival in comparison to non-surgical therapies is necessary.


Subject(s)
Carcinoma, Bronchogenic/therapy , Lung Neoplasms/therapy , Noninvasive Ventilation/methods , Pneumonectomy/rehabilitation , Adult , Aged , Carcinoma, Bronchogenic/epidemiology , Female , Humans , Length of Stay/statistics & numerical data , Lung Neoplasms/epidemiology , Male , Middle Aged , Noninvasive Ventilation/statistics & numerical data , Pneumonectomy/statistics & numerical data , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Preoperative Period , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...